Emerging studies suggest Retatru tide , a dual stimulator targeting both GLP-1 and glucose-dependent insulinotropic polypeptide , may offer a promising advancement for obesity loss . Preliminary patient trials have demonstrated substantial losses in visceral mass , potentially outperforming existing weight-loss therapies . Nevertheless , more study